Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS)

Q: What does CUSIP 92859E207 represent in this 13F holders report?

CUSIP 92859E207 is the security identifier for VVOS - Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held VVOS - Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share in Q2 2024?

18 institutional investors reported VVOS - Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share for Q2 2024. Use the holders table for investor-level position and value details.

CUSIP: 92859E207

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Common stock, par value $0.0001 per share
Total 13F shares: 186,896
Total 13F value: $433,846
Share change: -78,267
SEC-reported price per share: $2.22
Number of holders: 18
Value change: -$444,091
Number of buys: 8
Number of sells: 3
Shares outstanding: 20,493,833

Security key

92859E207

Report period

Q2 2024

Institutions

Top holders

VVOS full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Vivos Therapeutics, Inc. SEC filings Vivos Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 92859E207

Newer quarter: Q3 2025

Recent filing periods:

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of VVOS - Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Gurdev Dave Singh

Disclosed value leader

Gurdev Dave Singh

Comparable rows

0/15

Latest evidence

20 Jun 2024

3/4/5 13F Highest disclosed value: $1,728,844 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Gurdev Dave Singh has the largest disclosed position value at $1.73M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Gurdev Dave Singh's linked filing trail.

Disclosed position value Top 5

Gurdev Dave Singh $1.73M

ARMISTICE CAPITAL, LLC $500.3K

COMMONWEALTH EQUITY SERVICES, LLC $72K

VANGUARD GROUP INC $51.1K

Matthew Thompson $16.8K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Gurdev Dave Singh	3/4/5 Chief Medical Officer, Director, 10%+ Owner 3/4/5	— mixed-class rows	$1,728,844 3,266,372 shares mixed-class rows	—	05 Aug 2021
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$500,301 103,582 shares	—	31 Mar 2024
COMMONWEALTH EQUITY SERVICES, LLC	13F Company 13F	— denominator unverified	$72,000 15,000 shares	—	31 Mar 2024
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$51,097 10,579 shares	—	31 Mar 2024
Matthew Thompson	3/4/5 Director 3/4/5	— denominator unverified	$16,819 7,067 shares	—	20 Jun 2024
NFSG Corp	13F Company 13F	— denominator unverified	$9,419 1,950 shares	—	31 Mar 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

186,896

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q2 2026 Across Filers

Q2 2026 holders

Q2 2024 holders

Holder diff

-3

Investor	Q2 2026 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q2 2026 value	Q2 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend